BamSEC and AlphaSense Join Forces
Learn More

Matinas Biopharma Holdings Inc. – Indentures

NYSE American: MTNB    
Share price (8/4/26): $0.29    
Market cap (8/4/26): $1.861 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 8-K 17 pages Solicitation Agent Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.3
from 425 17 pages Solicitation Agent Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.2
from 425 21 pages Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.2
from 8-K 21 pages Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.1
from 425 16 pages Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.1
from 8-K 16 pages Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.6
from S-3 55 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1
12/34/56
EX-4.5
from S-3 52 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1
12/34/56
EX-4.2
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from 10-Q 3 pages Omnibus Warrant Amendment
12/34/56
EX-4.2
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 20 pages Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.6
from 10-Q 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Matinas Biopharma Holdings, Inc
12/34/56
EX-4.6
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-3 54 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.5
from S-3 51 pages Matinas Biopharma Holdings, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.6
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56